Arrow®

AC3 Optimus Intra-Aortic Balloon Pump®

IABP performance evolved

Simplicity, right from the start
The AC3 Optimus® Intra-Aortic Balloon Pump is up and running with the push of a button. Set up is fast and easy, guided byvisual prompts on the large, high-definition touchscreen — including confirmation that therapy can be initiated. Delivering
advanced IABP support to even the most compromised patient has never been so simple.
360° viewable illuminating
switch indicates pump isalarming and the priority level

Touchscreen accessto alarm settings

Most IABP functions arecontrolled with six keys

Adjust balloon volume
by 0.5cc increments
Balloon volume

Heart rate with assisted andunassisted hemodynamic
values is clearly displayed inseparate colors

A touch of the waveform
accesses signal-related
controls for lead selection
and scaling100%

36.5 cc

Done

Easy to connect horizontal
FOS port

Enhanced value

Exceptional service

Beyond its clinical value, the AC3
Optimus® IABP offers low cost ofownership. As budget pressurescontinue to grow, cost-effective
features like these become
increasingly appealing:Teleflex is committed to providing attentive
and responsive support. In customer
surveys regarding Teleflex IABP service
programs:*• Pneumatic drive system withno scheduled replacement parts

97.5%• Low component
replacement costs

97.5% of surveyedcustomers said theirservice representative
was knowledgeable
about our products
and services

95% of surveyedcustomers were overallsatisfied with their lastinteraction with theircustomer service
representative

95%

95%

95% of surveyedcustomers said they
were likely to referothers to Teleflex*Based on customer surveys conducted by Teleflex.

Third-generation AutoPilot Mode®

More than advanced, approachable
A user-friendly design, intuitive interface, and state-of-the-art AutoPilot ® Mode makes the AC3 Optimus® IABP simple to use.
With this powerful combination, Teleflex counterpulsation therapy is more accessible than ever.

• Built for ease-of-use• Therapy Status Report

Simple, clean design, large display, fewer keys,
mobility/portability

Quick and easy access to documenting therapy status• Graphics• Getting started checklist

Simple green, yellow, and red graphics allow
for communication of parameter status

Provides simple and quick confirmation that routine
tasks have been completed• Alarm history report• Touchscreen

Allows interpretation of alarm history to assess
impact on therapy

Allows for fast and easy interaction. Action bar
combines assessment and action in a single location

Key actions and assessments made easy and accessible:
Getting Started

Alarm History
Date:

Time:

1. 12/03/2015

16:06

×1) Check Helium Supply

Alarm:ECG LEAD FAULT RA

2. 12/03/2015

16:05

ECG TRIGGER LOSS

3. 12/03/2015

16:05

ECG LEAD FAULT RA

4. 12/03/2015

16:05

ECG LEAD FAULT RA

5. 12/03/2015

16:05

ECG TRIGGER LOSS

6. 12/03/2015

16:05

ECG LEAD FAULT RA

7. 12/03/2015

16:05

ECG LEAD FAULT RA

8. 12/03/2015

16:05

ECG LEAD FAULT RA

9. 12/03/2015

16:05

ECG LEAD FAULT RA       Helium Verified
2) Connect ECG and AP

Therapy Status
HR
SYS (A/U)
AUG

81 bpm109 / -- mmHG
126 mmHG    Trigger Verified

DIA (A/U)

51 / -- mmHG

3) Connect IAB		

MAP (A/U)

96 / -- mmHG		

Assist Ratio

IAB Volume: 40cc

Start Pump

FOS (Optional)
1) FOS CAL Data Read (Loaded)
2) FOS Sensor Connected		

BVOL

1:1
40.0 cc
AfibTrigger Mode
Mode
Timing Method (I/D)
Timing Settings

Autopilot
Wave / RWave
30 msec - Rwave
OnAlarms

3) Auto Zero in ProgressDone4) Auto Zero is Complete,

Done

Insert IAB

AP Waveform Present

Access to alarm history allows forquick review of past alarms and theability to assess repeated alarms.

An interactive review of the threestep startup and confirmation
when the pump is ready to start.

One-button summary of patient
hemodynamics (response to IABPtherapy) and therapy settings. Allowsfor one key stroke charting, with ability
to print reports.

Innovative features from the third-generation AutoPilot® ModeDeflation timing management

Up to 200 bpm

Best signal analysis

Automated to provide real-time andcomprehensive deflation timing.

Provides precise and accurate
support for patients with severe
arrhythmias and heart rates ashigh as 200 bpm.1

Continuously analyzes up to 6 ECG
sources in two trigger modes to
identify the optimal trigger. 2

IntraBeat™ Timing:

An advanced solution for a growing problem
To address a growing population of arrhythmic patients 3, the AC3 Optimus® IABP features IntraBeat™ Timing. It determines
individual AV closure points to provide remarkable accuracy during IABP support, even in patients with severe arrhythmias.1,4,5
The AC3 Optimus® IABP can help your facility be better equipped for your current and future patient populations.

Projected Prevalence Of Diagnosed

Prevalent Number of AF Cases in U.S. (Millions)

3
Projected prevalenceofUnited
diagnosed
AF Cases In
States AF cases in United States

Accurate timing is critical to IABP performance. Early inflation
timing errors can have negative effects on IABP therapy,
including a decrease in stroke volume by as much as 20% (+/-6% to -55%).6 Late deflation is also associated with less-thandesirable hemodynamic responses.5,6

13.0
12.0
11.0
10.0
9.0
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.00

2010

2015

2020

2025

2030

The solution? IntraBeat™ Timing for accurate inflation andAutoPilot ® Mode for controlled deflation timing management.
The AC3 Optimus® IABP makes it easy to track, sense, andadapt to changing conditions without routine clinician
intervention, allowing the clinician to focus on what mattersmost — the patient.

YearProjected prevalence of diagnosed AF cases in United States from 2010 to 2030,
assuming (1) no increase in incidence rate after 2007 (solid line) and (2) alogarithmic growth in AF incidence (line with circles).

The problem: The arrhythmic patient.

The challenge: In published literature, conventional timing only showed 4 out of 16
beats were accurately timed.5

Early
Early

Early Early
Early

Early

Late
Early

The solution: IntraBeat™ Timing has shown 98.1% accurately timed beats in severe arrhythmia.1

ECGAPFiberOptix

Representative of study. Individual results may vary.

Immediate support with patented technology
The AC3 Optimus® IABP is designed to deliver support from the very first beat, increasing the volume of blood while
decreasing blood pressure.6,10 Accurate aortic flow and pressure is maintained by two proprietary solutions — Flow
Conversion and WAVE® Algorithm.

IABP: Immediate support6,10

Aortic Flow Wave

Two proprietary solutions: Flow Conversion,
WAVE ® Algorithm1,10120

Arterial Pressure
Aortic Flow

100%

100

Flow (%)

80
60
4020%

200-20AV Closes-4000.1

0.2Time (s)2018 Medical DesignExcellence winner
The AC3 Optimus® IntraAortic Balloon Pump wasnamed a bronze winner inthe cardiovascular device
category of the 20th annual
Medical Design ExcellenceAwards competition —the industry’s premierdesign competition.

0.3

0.4

Managing risk with Protective Pumping Technology™

While a larger balloon has been shown to improve augmentation, it does not come without potential risks.7,8,9

Patient height and BMI have long been themeasuring tools for IABP sizing selection;
however, recent studies have shown poorcorrelation of aortic length to height.7,8,9

There are a variety of risks associated withIABP therapy, including among others:7,8,9• Risk of balloon rupture• Risk of thromboembolism• Risk of thrombocytopenia/hemolysis• Risk of compromised organ perfusion

The Goal:
90—95% Occlusive10

Monitoring pressure to optimize balloon sizing
Compare the pressure within the balloon to the augmented pressure. Protective Pumping™ Technology, another AC3 Optimus®
IABP exclusive feature, allows for measurement of the balloon within the aortic space to determine proper sizing.

For illustrative purposes onlyReferences:
1.

Donelli A, Jansen JRC, Hoeksel B, et al. Performance of a real-time dicrotic notch detection and prediction algorithm in arrhythmic human aortic pressure signals. J Clin Monit.
2002;17(3-4):181-185. Study sponsored by Teleflex.

2.

Torracca, L. Overcoming electro-surgical inference in IABP therapy with the combined use of AutoPilot and FiberOptix IAB sensor signal. 2007. (case report, data on file).
Study sponsored by Teleflex.

3.

Susan Colilla, PhD, MPHa, Ann Crow, MLSb, et al. Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population. Am J Cardiol.
2013 Oct 15;112(8):1142-7

4.

Hoeksel S, Jansen J, Blom J, & Schreuder J,. Detection of dicrotic notch in arterial pressure signals. J Clin Monit. 1997;13(5),309-316. Study sponsored by Teleflex. Dr. Schreuder
was formerly a paid consultant of the study sponsor.

5.

Schreuder J, Castiglioni A, Donelli A, et al. Automatic intraaortic balloon pump timing using an intra beat dicrotic notch prediction algorithm. Ann Thorac Surg.
2005;79(3):1017-1022. Study sponsored by Teleflex. Dr. Schreuder was formerly a paid consultant of the study sponsor.

6.

Schreuder J, Maisano F, Donelli A, et al. Beat-to-beat effects of intra-aortic balloon pump timing on left ventricular performance in patients with low ejection fraction. AnnThorac Surg. 2005;79(3):872-880. Study sponsored by Teleflex. Dr. Schreuder was formerly a paid consultant of the study sponsor.

7.

Parissis et al. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. Journal of Cardiothoracic Surgery 2011, 6:147

8.

Young-Seok Cho, Cheong Lim, et al. Should We Consider the Ethnic Difference in Selecting Size of Intraaortic Balloon by Commercial Guideline?
ASAIO Journal 20099.

Ardawan Julian Rastan, MD, PhD; Eugen Tillmann, MD et al. Visceral Arterial Compromise During Intra-Aortic Balloon Counterpulsation Therapy. Circulation.
2010;122[suppl 1]:S92–S99

10. Parissis, H, Soo, A, Leotsinidis, M, and Dougenis, D, A statistical model that predicts the length from the left subclavian artery to the celiac axis; towards accurate intra
aortic balloon sizing. Journal of Cardiothoracic Surgery. 2011, 6:95.
11. Data on file

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia,cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow ®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch®, and Weck® – trusted brands united by acommon sense of purpose.

Corporate Office
Phone +1 610 225 6800, 550 E. Swedesford Road, Suite 400, Wayne, PA 19087, USA

Regional Offices
United States: Phone +1 919 544 8000, Toll Free 866 246 6990, cs@teleflex.com, 3015 Carrington Mill Boulevard,
Morrisville, NC 27560, USA
Latin America: Phone +1 919 433 4999, la.cs@teleflex.com, 3015 Carrington Mill Boulevard, Morrisville, NC 27560, USA
International: Phone +353 (0)9 06 46 08 00, orders.intl@teleflex.com, Teleflex Medical Europe Ltd.,IDA Business and Technology Park, Dublin Road, Athlone, Co Westmeath, Ireland
For more information, please visit teleflex.com.

Teleflex, the Teleflex logo, Arrow, AC3 Optimus, AutoPilot, IntraBeat, Protective Pumping and WAVE are trademarks or registered trademarks of Teleflex
Incorporated or its affiliates, in the U.S. and/or other countries.
Information in this material is not a substitute for the product Instructions for Use. Not all products may be available in all countries. Please contact yourlocal representative. Revised: 08/2019.
© 2019 Teleflex Incorporated. All rights reserved. MC-005536 · Rev 0.1